Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,845
Total Claims
$1.6M
Drug Cost
1,021
Beneficiaries
$1,555
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+46%
Cost per patient vs peers
$1,555 vs $1,068 avg
+42%
Brand preference vs peers
12.8% vs 9.0% avg
Brand vs Generic
Brand: 1,760 claims · $1.3M
Generic: 11,998 claims · $263K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 101 | $174K |
| Semaglutide | 110 | $164K |
| Dapagliflozin Propanediol | 104 | $151K |
| Fluticasone/Umeclidin/Vilanter | 74 | $115K |
| Apixaban | 75 | $63K |
| Sitagliptin Phosphate | 59 | $62K |
| Mirabegron | 44 | $49K |
| Dulaglutide | 24 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $30K |
| Linaclotide | 25 | $28K |
| Linagliptin | 14 | $22K |
| Rivaroxaban | 17 | $21K |
| Sitagliptin Phos/Metformin Hcl | 15 | $19K |
| Rosuvastatin Calcium | 532 | $18K |
| Insulin Detemir | 18 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data